CAS Number: 8015-60-9
Aerial summits and seeds are used. It contains a great deal of flavonoids, steroids, cumestans, vitamins and minerals Attributed effects but not clinically tested are: agonist of estrogen, antianemic and diuretic. Also, there is not reliable data that would support its use as galactagogue. At latest update, relevant published data on excretion into breast milk were not found. Because its estrogenic effect it should not be consumed during pregnancy and breastfeeding. Caravanina which is one of the components, is toxic if continuously used. Pancytopenia, Hemolytic anemia and Lupus Erythematosus have been described as induced by frequent consumption of germinated-seeds or tablets of alfalfa. Cautious measures before consumption of herbal infusions should include: 1. Make sure that the source is reliable: occurrance of intoxication cases after mistakenly use of a toxic plant, poisoning by consumption of heavy metal containing substances or contaminated food by bacterial or fungal toxins. 2. Avoid excessive use. The “natural products” are not harmless at whatever dosage: the plants contain active substances that have been the source of our common pharmaceutical drugs. They may be a cause of poisoning if consumed in high quantity or for a long time.
CAS Number: 90046-12-1
Seaweeds contain large amounts of mucilage and minerals, including iodine which appears in variable amounts that can be significant, in such a way that it may be a cause a hyperthyroidism-like disease (anxiety, insomnia, tachycardia, palpitations).It may also contain heavy metals, being a species of seaweed with a high ability of contamination by toxic products. Seaweed consumption increases levels of iodine in plasma and breast milk.There have been reports of hypothyroidism in infants whose mothers have included in their diet important quantities of seaweed. There is no evidence of effectiveness on increasing milk production. The most effective method to increase milk production should be done by strengthening maternal self-confidence, evaluate and correct problems along with an effective support to breastfeeding mothers. It is recommended to obtain information on the composition of any particular algae and avoid it or use it in very moderate amount in case of iodine content would be important.
CAS Number: 84696-05-9
Roots and leaves are used. It contains allantoin, tannins, and pyrrolizidine alkaloids. Unproved effect: topical anti-inflammatory. Indications after Commission E of German Ministry of Health: contusion with undamaged skin. Do not apply on the breast. Pyrrolizidine alkaloids are highly hepatotoxic and poses an increased risk of liver carcinoma and cirrhosis to both the mother and the infant. Consider not to use it at all.
CAS Number: 471-34-1
Various calcium salts (Acetate, Carbonate, Chloride, Citrate, Phosphate, Gluceptate, Glucobionato, Lactate, Laxctobionato Pidolate, Silicate) are used in the management of hypocalcemia, supplements for treating calcium deficiency states and antacids ( Carbonate and Silicate) Daily requirement of calcium during lactation are 1 g (1.3 g in children under 20 years).Calcium supplements in the diet does not affect the concentration of calcium in milk.Excessive intake of calcium is not good for health. During lactation, consumption of calcium should not exceed 2.5 g a day. WHO List of Essential Medicines 2002 states that it is compatible with breastfeeding.
Several ferrous salts of iron (ascorbate, aspartate, citrate, chloride, fumarate, gluconate, lactate, oxalate, succinate, sulfate, glycine sulfate, etc.) are used in oral administration for treating or preventing iron deficiency anemia.Its molecular weight varies from 170 for the fumarate and succinate, and from 280 for lactate and sulfate to 400 for aspartate and ascorbate. Characteristics of iron metabolism in the body make unlikely that it would be excreted in a significant amount into breast milk.It is a medication used for treatment of Neonatal Anemia in premature babies. Iron is excreted in small amounts in human milk, usually being enough for covering the daily needs of infants due to its high bioavailability. There is no correlation between mother's daily intake of iron and its concentration in breast milk.Iron supplementation to the mother does not increase levels of iron in breast milk or infant plasma significantly. Excessive supplementation can reduce the zinc concentration in milk. WHO List of Essential Medicines 2002: compatible with breastfeeding.
A polymer made out of silicon-oxygen-methyl combination with a high molecular weight, water repellent and low superficial tension. It is used in many ways (dimethicone, simethicone, -see specific items)orally to treat infant colic and flatulence; as pediculicide, in cosmetic creams and lotions and skin protectants as to prevent ulcers and scars; arthroplasties, retinal detachments and reconstruction or cosmetic surgery as injections and implants. Silicone is widely distributed in our environment with several cosmetic and medicinal uses. No evidence of toxicity on human tissues has been shown. A 1994 report on immunological side effects in infants breastfed by mothers with silicone implants, was denied categorically by means of meta-analysis and other work. The absorption by oral or dermal route is negligible. Both a high molecular weight and polymer molecular structure make it practically impossible excretion in the milk and hence a significant amount of intestinal absorption by the infant. Those circumstances make silicone implants safe for lactation even if broken or manufacturing fault (Poly Implant Prothèse, PIP). After extensive analysis of such silicone prosthesis, where lack of health risk was demonstrated, it can be concluded that many of the initial recommendations published lacked scientific validity, including that carriers of such prosthesis should not breastfeed. Silicon levels in blood and milk of women with implants (55 ng / ml) are similar to those of women without implants (51 ng / ml), 13 times lower than that found in cow's milk (709 ng / ml) and 80 times lower than in commercial infant formulas (4403 ng / ml). American Academy of Pediatrics: Product usually compatible with breastfeeding. To view other possible effects on breastfeeding of breast implant unrelated to silicone, see the term 'Augmentation Mammoplasty'. See below the information of these related products:
CAS Number: 7553-56-2
Disinfectant that contains high amount (2-7%) of Iodine in solution with alcohol or water (Lugol's solution) Not absorbed through intact skin of adults. However, it may trespass the inflamed skin, wounds, mucosa surfaces like vagina, in which case can reach concentration in grams in the human serum (1 g = 1,000 milligrams = 1,000,000 micrograms). Normal daily allowance is considered to be as high as 100 to 150 micrograms that increases to 200 – 300 micrograms in pregnancy or nursing period. The latter means less than one third of a milligram. Iodine is concentrated into breast milk with a level that could reach 20 times higher than the concentration in the blood. It has been found higher levels of Iodine, altered results of neonatal screening test for thyroid function, and, transient hypothyroidism in infants whose mothers were exposed to Iodine Povidone. Use should be avoid in the Delivery Room, Operating Room (C-section), Neonatal Units, Toddler admision areas and during the breastfeeding period. Sporadic or inadvertent use, specially on normal skin, does not require special test or procedures because it does not pose higher risk to the child.
CAS Number: 64-17-5
While breastfeeding it is recommended to avoid use of alcohol or do it occasionally and moderately (ABM 2015). Drinking beer does not increase milk production (Mennella 1993-2001, Comité Lm AEP 2012). Long term consumption may cause: sedation, failure to thrive, psychomotor delay in the infant (Little 1989, Moretti 2000, Koren 2002, Backstrand 2004, Sachs 2013), although the data are inconsistent (Little 2002, Haastrup 2014, ABM 2015). One case of Pseudo-Cushing Syndrome was reported that disappeared after alcohol stop by the mother (Moretti 2000). It is controversial that alcohol consumption is associated with shorter duration of breastfeeding (Giglia 2008, Rebhan 2009, Mgongo 2013). Despite of low increase of Prolactin serum level (Sarkola 1999), acute consumption affects the infant with sedation, and, inhibits Oxytocin secretion in the mother (Cobo 1973, Coiro 1992, Chien 2009) and hence affects the ejection reflex of breast milk with a decrease of 10% to 25% of milk production (Mennella 1991-1993-1997-1998-2001-2005). Excessive acute ingestion by the mother may induce coma, seizures and danger of death in the infant (Swiderski 2011). Both beer 0.0% and non-alcoholic (<1%) may be drunk by the nursing mother (Koletzko 2000, Schneider 2013). Increase of anti-oxidant properties of the milk have been recognized (Codoñer 2013). Elapsing time required to resume breastfeeding after occasional consumption of alcohol by the mother in order to ensure disappearance of milk and blood (Ho 2001) depends on mother's body weight (lesser weight needs longer time to wait), and, on the amount ingested (higher amount needs longer time). Stop breastfeeding for longer than two and a half hour for every 10 - 12 g of ingested alcohol: 330 mL of 4.5% beer, 120 mL (1 glass) of 12% wine, or, one cup of 40% - 50% liquor. Suggested time-periods to stop breastfeeding for a 60 kg of body weight woman are: 1 glass of wine = 2.5 hours; 660 mL of beer = 5 hours; 3 cups of liquor = 7.5 hours (ABM 2015: See reference values at Can Fam Physician 2002) Some medicinal products containing high concentrations of alcohol as an excipient should be avoided during breastfeeding (Nice 2000). Avoiding bed-sharing is recommended to mothers who have drunk alcohol (UNICEF 2006, ABM 2008, Landa 2012, UNICEF 2013). When topically used as disinfectant, alcohol is compatible with breastfeeding (WHO 2002).
CAS Number: 8015-60-9
Alfalfa (Medicago sativa) leaves and sprouts contain saponins, estrogenic isoflavinoids (e.g., dianzein genistein), vitamin K, and the amino acid L-canavanine. Alfalfa is a purported galactogogue and is included in some proprietary mixtures promoted to increase milk supply; however, no scientifically valid clinical trials support this use. Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production. Dianzein and genistein are excreted into breastmilk in small amounts, but have not been measured specifically after alfalfa intake. No data exist on the excretion of other components of alfalfa into breastmilk or on the safety and efficacy of alfalfa in nursing mothers or infants. Alfalfa is generally well tolerated and is "generally recognized as safe" (GRAS) as a food by the U.S. Food and Drug Administration. Worsening of systemic lupus erythematosus has been reported, possibly caused by immune system stimulation by L-canavanine. Because of its vitamin K content, alfalfa should be avoided in persons taking warfarin. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 84696-05-9
Comfrey (Symphytum officinalis) herb and leaf contains allantoin and rosmarinic acid; comfrey also contains pyrrolizidine alkaloids. Comfrey preparations have been used topically for pain following episiotomy and cracked, painful nipples, either as aqueous preparations or in creams and ointments. Scientific evidence of effectiveness for these indications is minimal. The pyrrolizidine alkaloids in comfrey can cause severe liver damage, liver cancer, mutagenicity, and even death. For this reason, the U.S. Food and Drug Administration has banned the sale of oral comfrey products in the United States. Furthermore, most sources consider topical use of comfrey during breastfeeding to be contraindicated. If it is used on the skin, it should only be applied to intact skin away from the breast on the smallest area of skin possible, and for a limited duration. It is particularly important to ensure that the infant not come into direct contact with the areas of skin that have been treated, because ingestion may cause severe liver damage. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 7553-56-2
Iodine is an essential trace nutrient for all infants that a normal component of breastmilk. Infant requirements are estimated to be 15 mcg/kg daily in fullterm infants and 30 mcg/kg daily in premature infants. Systematic reviews and studies on iodine nutrition found that iodine in breastmilk is adequate in iodine-sufficient countries, but in countries with iodine fortification of foods, many mothers did not obtain adequate iodine and that additional supplementation was desirable. In iodine-deficient areas, supplementation of breastfeeding mothers with iodine appears to be more effective than direct supplementation of the infant in reducing infant iodine deficiency. The American Thyroid Association recommends that breastfeeding women should supplement their diet with a daily oral supplement that contains 150 mcg of iodine, but sustained iodine intake while breastfeeding that exceeds 500 to 1100 mcg daily should be avoided. A survey in the United States between 2011 and 2014 found that only 19% of lactating women used a dietary supplement that contained iodine. The use of excessive amounts of iodine in the mother near term and during breastfeeding (e.g., seaweed soup) can increase breastmilk iodine levels and cause transient hypothyroidism in breastfed infants. The absorption of iodine can be marked after application to open wounds or mucous membranes. Exposure of mothers to unnecessary iodine who are or will be breastfeeding should be avoided or minimized to the extent possible by avoiding its use on maternal mucous membranes (e.g., vaginal use, wound therapy), avoiding prolonged contact time, avoiding repeated applications, and applying it to the smallest possible surface areas of the body. It is possible that maternal exposure to iodine near term could interfere with thyroid studies done as a part of newborn screening tests.
CAS Number: 3344-18-1
No information is available on the clinical use of magnesium citrate during breastfeeding. However, other magnesium salts have been studied. Intravenous magnesium sulfate increases milk magnesium concentrations only slightly. Oral absorption of magnesium by the infant is poor, so maternal magnesium citrate is not expected to affect the breastfed infant's serum magnesium. Magnesium citrate supplementation during pregnancy might delay the onset of lactation, but it can be taken during breastfeeding and no special precautions are required.
CAS Number: 64-17-5
The effects of maternal alcohol (ethanol) ingestion during lactation are complex and depend on the pattern of maternal drinking. Alcohol decreases milk production, with 5 drinks or more decreasing milk letdown and disrupting nursing until maternal alcohol levels decrease. Beer may increase serum prolactin levels during nursing because of polysaccharides from barley and hops. After ingestion of nonalcoholic beer, the antioxidant capacity of milk is increased, but alcohol levels in milk are negligible. Women with a family history of alcoholism have a blunted prolactin response following breast stimulation and tend to breastfeed more frequently to compensate. Breastmilk alcohol levels closely parallel blood alcohol levels. The highest alcohol levels in milk occur 30 to 60 minutes after an alcoholic beverage, but food delays the time of peak milk alcohol levels. Nursing after 1 or 2 drinks (including beer) can decrease the infant's milk intake by 20 to 23% and cause infant agitation and poor sleep patterns. The long-term effects of daily use of alcohol on the infant are unclear. Some evidence indicates that infant growth and motor function may be negatively affected by 1 drink or more daily, but other studies have not confirmed these findings. Heavy maternal use may cause excessive sedation, fluid retention, and hormone imbalances in breastfed infants. Casual use of alcohol (such as 1 glass of wine or beer per day) is unlikely to cause either short- or long-term problems in the nursing infant, especially if the mother waits 2 to 2.5 hours per drink before nursing, and does not appear to affect breastfeeding duration. Daily heavy use of alcohol (more than 2 drinks daily) may affect infants negatively and appears to decrease the length of time that mothers breastfeed their infants. Nursing or pumping within 1 hour before ingesting alcohol may slightly reduce the subsequent amounts of alcohol in breastmilk.
In most cases, it is okay to take mineral supplements like iron, calcium and copper. These have not been known to affect breast milk levels. However, taking large amounts of a dietary supplement while breast-feeding may be harmful to the mother and/or baby and should be avoided.
Next to calcium, phosphorus is the most abundant mineral in the body, making up about 1% of total body weight. Calcium, which gives strength to bones and teeth, needs to be combined with another mineral, such as phosphorous, to become stabilized before it can be effective.
Phosphorus also helps to release energy from food as it plays an important role in the metabolism of carbohydrate, fat and protein. Phosphorus is naturally found in many food sources and phosphorus supplementation while breastfeeding is mostly safe.
You can easily get all the phosphorus you need from a well-balanced diet (even though most prenatal vitamins dont contain phosphorus). For example, 2 cup of yogurt provides nearly all your phosphorus for the day.Warning: Consuming high doses of phosphorus for a short time can cause diarrhea or stomach pain. The long term over-consumption of foods high in phosphorus can deplete calcium resources and lead to reduced bone mass, which means that bones are more likely to fracture.
Due to high dilution of ingredients in homeopathic medicines they do not create much problem for baby. Geopathic Stress is a homeopathic medicine and if your baby does not have any abnormal symptoms then there is nothing to worry about. Be careful with too much usage of ethanol based homeopathic medicines during breastfeeding.
Homeopathic medicines are usually safe in breastfeeding and if Geopathic Stress has been recommended by doctor then there should be no concern about its usage in breastfeeding.
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week